InvestorsHub Logo
Followers 828
Posts 119319
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 2397

Friday, 01/06/2023 3:23:16 PM

Friday, January 06, 2023 3:23:16 PM

Post# of 2911
Additions/changes in ENTA’s most recent slide set:

• Slides 17-18 have info on the new program for dual inhibition of hMPV and RSV.

• Slide 21 has new info about EDP-235’s live-virus potency against Omicron and other strains.

• Slide 22 has new preclinical EDP-235 info from a ferret model, including data on viral transmission from animal to animal.

• Slide 25 has a graphic on the design of the (in-progress) phase-2 trial for EDP-235.

• Slide 27 has info on the new program to develop a papain-like protease inhibitor for SARS-CoV-2.

• Slide 35 has a list 2023 catalysts.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News